Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata significantly lowers quality of life, especially in personal and social areas, and more so if the patient is also depressed.

Age, smoking, and lower BMI increase facial wrinkles; men wrinkle more than women, except in old age; pale skin and certain hormonal factors can protect against wrinkles.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

Insulin resistance is common in PCOS patients and linked to obesity and increased cardiovascular risk.

Lulican™ shampoo is more effective and better tolerated than Ketoconazole for treating scalp seborrheic dermatitis.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Effective acne treatment varies by type, with topical and oral medications showing strong evidence, and patient education and support are crucial.

Oral minoxidil improved hair loss more than oral dutasteride.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Non-invasive methods can effectively diagnose and manage alopecia areata.

Women with PCOS often have sleep problems, including sleep apnea, which are linked to obesity and depression.

Some migraine sufferers had no more headaches after getting a hair transplant.

Some treatments work better for different types of hair loss, and nutrients like iron and L-lysine are important for preventing hair loss.

Rituximab can cause skin issues, but baricitinib may help improve them.

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

Scalp coverage scoring accurately measures hair loss and treatment effectiveness.

Men with androgenetic alopecia may have a higher risk of metabolic syndrome.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Machine learning can predict symptoms and quality of life in chronic skin disease patients using smartphone app data, and shows that app use varies with patient characteristics.

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

Patients using social media have mixed feelings about alopecia treatments, noting hair growth but also frustration with treatment recurrence.

The electronic version of the Dermatology Life Quality Index is as effective as the paper version, with most patients preferring it.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

The AAPPO questionnaire is a reliable tool for assessing hair loss impact in alopecia areata patients.

Effective treatments for lichen planopilaris are unclear due to inconsistent results and a lack of strong research evidence.

Climate factors like UV index and rain can affect alopecia areata flares in children, especially those with allergies.

Unani medicine effectively reduced hair loss in a 24-year-old woman without side effects.

The Polish version of the Alopecia Areata Quality of Life Index is a reliable tool for assessing quality of life in Polish-speaking patients with alopecia areata.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.